Top Markets
#1 Black Phoenix Black Phoenix +166.82%
#2 Islamic Coin Islamic Coin +158.16%
#3 Glidr Glidr +84.34%
#4 Acurast Acurast +29.06%
#5 Cryptopia Cryptopia +20.92%
#6 Quantum Resistant Ledger Quantum Resistant Ledger +18.86%
#7 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.84%
#8 Test Test +13.79%
#9 Wrapped Bitcoin (PulseChain) Wrapped Bitcoin (PulseChain) +10.94%
#10 Bluwhale Bluwhale +10.65%
Coin of the day
Black Phoenix Black Phoenix
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
ARYx Therapeutics, Inc. ARYx Therapeutics, Inc.

ARYx Therapeutics, Inc.

ARYX
Rang in Aktien #41544
Based in Fremont, California, and established in 1997, ARYx Therapeutics, Inc.... Based in Fremont, California, and established in 1997, ARYx Therapeutics, Inc. is dedicated to discovering and advancing innovative treatments, primarily focusing on widespread, chronic conditions addressable with oral medications. The company utilizes its unique RetroMetabolic Drug Design technology to engineer distinctive molecular compounds that maintain the therapeutic effectiveness of their original counterparts. Its clinical development portfolio includes several promising candidates: Tecarfarin (ATI-5923): An oral anticoagulant currently in Phase III clinical trials, aimed at preventing hazardous blood clots in at-risk patients. Budiodarone (ATI-2042): An oral antiarrhythmic agent undergoing Phase IIb development for managing atrial fibrillation, a form of irregular heart rhythm. ATI-7505: An oral prokinetic agent in Phase IIb clinical development, targeting various gastrointestinal issues such as chronic constipation, gastroparesis, functional dyspepsia, irritable bowel syndrome with constipation, and gastroesophageal reflux disease. ATI-9242: An antipsychotic agent progressing through Phase I clinical trials for the treatment of schizophrenia and other psychiatric conditions. Additionally, ARYx Therapeutics is conducting early-stage research on ATI-20,000 for metabolic disorders and ATI-24,000 for gastrointestinal ailments.
Aktienkurs
$0.0005
Zuletzt synchronisiert: 2026-08-11
Marktkapitalisierung
$16.73K
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
0.00%
Land
US
Handel ARYx Therapeutics, Inc. (ARYX)

Kategorie

Healthcare
Preis ARYX mit Marktkapitalisierung von B
ARYx Therapeutics, Inc. ARYx Therapeutics, Inc.
ARYX
$0.0005
Marktkapitalisierung von ARYx Therapeutics, Inc.(ARYX)
Marktkapitalisierung: $16.73K
Mit Stand August 2026 hat ARYx Therapeutics, Inc. eine Marktkapitalisierung von $16.73K. Das macht ARYx Therapeutics, Inc. laut unseren Daten zum 41544th wertvollsten Unternehmen der Welt nach Marktkapitalisierung. Die Marktkapitalisierung ist der Gesamtmarktwert aller ausstehenden Aktien eines börsennotierten Unternehmens und wird häufig verwendet, um den Unternehmenswert zu bestimmen.
Marktkapitalisierung von ARYx Therapeutics, Inc. von 2007 bis 2026
ARYX im Vergleich zu den Top 5 der beliebtesten stocks
Preis für ARYX Vermögenswert B Marktkapitalisierung von B Ergebnisse
ARYx Therapeutics, Inc. ARYx Therapeutics, Inc.
$160,880 $16.73K
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.383T +32,175,957,463.80%
ARYx Therapeutics, Inc. ARYx Therapeutics, Inc.
$132,191 $16.73K
Apple Inc. Apple Inc.
AAPL
$4.423T +26,438,295,302.18%
ARYx Therapeutics, Inc. ARYx Therapeutics, Inc.
$124,331 $16.73K
Alphabet Inc. Alphabet Inc.
GOOG
$4.160T +24,866,232,636.13%
ARYx Therapeutics, Inc. ARYx Therapeutics, Inc.
$109,477 $16.73K
Microsoft Corporation Microsoft Corporation
MSFT
$3.663T +21,895,408,644.25%
ARYx Therapeutics, Inc. ARYx Therapeutics, Inc.
$86,403.35 $16.73K
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.891T +17,280,669,288.56%